ARK Investment Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-50,446
Closed -$2.14M 199
2024
Q1
$2.14M Sell
50,446
-4,820
-9% -$204K 0.01% 187
2023
Q4
$2.31M Sell
55,266
-2,295
-4% -$95.9K 0.01% 163
2023
Q3
$2.17M Sell
57,561
-24,058
-29% -$907K 0.02% 167
2023
Q2
$3.1M Buy
81,619
+10,294
+14% +$390K 0.02% 139
2023
Q1
$1.73M Buy
71,325
+3,413
+5% +$83K 0.01% 185
2022
Q4
$1.97M Buy
67,912
+6,625
+11% +$192K 0.02% 187
2022
Q3
$1.84M Buy
61,287
+5,347
+10% +$160K 0.01% 198
2022
Q2
$2.05M Buy
55,940
+374
+0.7% +$13.7K 0.01% 191
2022
Q1
$2.4M Buy
55,566
+6,307
+13% +$273K 0.01% 205
2021
Q4
$2.47M Sell
49,259
-1,908
-4% -$95.6K 0.01% 229
2021
Q3
$3.26M Sell
51,167
-25,431
-33% -$1.62M 0.01% 227
2021
Q2
$5.51M Sell
76,598
-2,029
-3% -$146K 0.01% 217
2021
Q1
$5.8M Buy
78,627
+50,606
+181% +$3.73M 0.01% 203
2020
Q4
$2.06M Buy
28,021
+15,325
+121% +$1.12M 0.01% 176
2020
Q3
$696K Sell
12,696
-2,418
-16% -$133K ﹤0.01% 176
2020
Q2
$1.01M Buy
15,114
+8,335
+123% +$554K 0.01% 161
2020
Q1
$415K Buy
6,779
+2,072
+44% +$127K 0.01% 143
2019
Q4
$414K Sell
4,707
-856
-15% -$75.3K 0.01% 145
2019
Q3
$420K Buy
5,563
+787
+16% +$59.4K 0.01% 157
2019
Q2
$408K Sell
4,776
-210
-4% -$17.9K 0.01% 158
2019
Q1
$539K Sell
4,986
-146
-3% -$15.8K 0.02% 121
2018
Q4
$434K Buy
5,132
+389
+8% +$32.9K 0.02% 128
2018
Q3
$466K Sell
4,743
-642
-12% -$63.1K 0.01% 151
2018
Q2
$623K Sell
5,385
-46
-0.8% -$5.32K 0.02% 111
2018
Q1
$536K Buy
5,431
+3,075
+131% +$303K 0.03% 129
2017
Q4
$247K Buy
+2,356
New +$247K 0.02% 141